SEGLUROMET 7.5 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

7.5 mg/1

Pack Size

180 TABLET, FILM COATED in 1 BOTTLE (0006-5370-06)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by combining two active ingredients, ertugliflozin and metformin hydrochloride, to improve blood sugar levels. This medication is typically prescribed alongside diet and exercise to support overall diabetes management. People often ask, 'What is Segluromet used for?' and the answer is that it is designed to assist in controlling high blood sugar levels associated with type 2 diabetes.

Side Effects

Common effects of Segluromet 7.5 mg/1 may include symptoms like nausea, diarrhea, or urinary tract infections. Some individuals might experience dizziness or low blood sugar levels. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Segluromet 7.5 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use, especially for those with kidney problems or a history of pancreatitis. Regular monitoring of blood sugar levels is recommended. Always store the medication as directed and keep it out of reach of children.

Avoid Interactions

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be avoided as it can increase the risk of low blood sugar. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions.

Frequently Asked Questions

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes by improving blood sugar control.

Segluromet 7.5 mg/1 is taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include nausea, diarrhea, and urinary tract infections.

It is important to consult a healthcare provider before taking Segluromet 7.5 mg/1 with other medications to avoid potential interactions.

Segluromet 7.5 mg/1 may not be suitable for everyone, especially those with certain medical conditions or allergies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.